Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
82 pending office actions • 60 art units • 78 examiners • 0 of 82 (0%) have an AI response strategy ready • 75 patents granted in the last 365 days
Washington University currently has 84 pending office actions in the Biotechnology & Pharmaceuticals technology area. These cases are spread across 81 distinct examiners, meaning that nearly every pending action is being reviewed by a different individual. The portfolio is also highly diverse technically, with 55 distinct art units involved in the 84 pending actions. MORGAN, BAILEY MICHELLE is the busiest examiner, currently handling 2 pending office actions.
The high number of 81 distinct examiners for 84 pending office actions indicates an extremely low level of examiner-level concentration. MORGAN, BAILEY MICHELLE is one of the few examiners with more than one case, and her 2 pending actions are a very small part of the total workload. The involvement of 55 distinct art units is particularly notable, as it suggests the university's research spans a vast range of specialized biological and pharmaceutical fields. This broad distribution requires a prosecution strategy that can adapt to the unique requirements of 55 different art units and 81 different examiners.
Based on the USPTO statutory response window for each pending office action. 24 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 24 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 18 (22%) |
| §103 only | 19 (23%) |
| §112 only | 8 (10%) |
| Double-patenting only | 3 (4%) |
| Double-patenting + other | 2 (2%) |
| Multi-statute (no §101) | 32 (39%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MORGAN, BAILEY MICHELLE | 2 | 56.3% | +58.3% |
| EBBINGHAUS, BRIANA NOEL | 2 | 59.7% | +63.0% |
| KALLAL, ROBERT JAMES | 2 | 59.4% | +31.2% |
| DUNN, MCKENZIE A | 2 | 53.7% | +57.1% |
| DAVIS, AMELIE R | 1 | 65.1% | +33.2% |
| DRISCOLL, LORA E BARNHART | 1 | 31.8% | +20.8% |
| TADAYYON ESLAMI, TABASSOM | 1 | 49.5% | +26.6% |
| SALVATORE, LYNDA | 1 | 64.2% | +19.1% |
| ADAMS, WILLIAM PATRICK | 1 | — | — |
| CAMMARATA, MICHAEL ROBERT | 1 | 69.7% | +34.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18310412 | ULTRAHIGH-SPEED MULTI-PARAMETRIC PHOTOACOUSTIC MICROSCOPY BASED ON A THIN-FILM OPTICAL-ACOUSTIC COMBINER | MENDOZA, ALEXANDRIA ARELLANO | 93d overdue |
| 18818523 | METHODS OF DETECTING ONCOGENIC FUSIONS AND USES THEREOF | LEITH, NANCY J | 43d overdue |
| 17914817 | Uses of Tau Phosphosites as Biomarkers for Alzheimer's Disease | FONTAINHAS, AURORA M | 42d overdue |
| 17628497 | PARTICLE-BASED METHOD FOR DEFINING A GUT MICROBIOTA IN HUMANS OR OTHER ANIMAL SPECIES | JONES, DAMERON LEVEST | 36d overdue |
| 18590933 | AEROSOL CONTAINMENT MASK AND METHODS OF USE THEREOF | LEE, MICHELLE J | 32d overdue |
| 18855529 | SYSTEMS AND METHODS FOR EXTRACTING CLINICAL PHENOTYPES FOR ALZHEIMER DISEASE DEMENTIA FROM UNSTRUCTURED CLINICAL RECORDS USING NATURAL LANGUAGE PROCESSING | LAGOY, KYRA RAND | 11d overdue |
| 17916180 | IMPLANT DEVICES AND METHODS FOR TREATMENT OF CERVICAL CANCER | WORSHAM, JESSICA N | 8d overdue |
| 18716989 | DEVICE FOR REVERSIBLY BLOCKING ACTIVITIES OF TARGET REGION AND APPLICATIONS OF SAME | CLARK, RYAN T | 5d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19358923 | ULTRASOUND SENSING AND IMAGING BASED ON WHISPERING-GALLERY-MODE (WGM) MICRORESONATORS | DAVIS, AMELIE R | — |
| 19312085 | RECOMBINANT ADENOVIRUSES AND USE THEREOF | DRISCOLL, LORA E BARNHART | — |
| 19170154 | CATALYST AND METHOD FOR CONVERTING CO2 TO SOLID CARBON, AND COMPOSITES INCLUDING SOLID CARBON | TADAYYON ESLAMI, TABASSOM | — |
| 19028550 | BIOMEDICAL PATCHES WITH SPATIALLY ARRANGED FIBERS | SALVATORE, LYNDA | — |
| 18970827 | COMPUTATIONAL REFOCUSING-ASSISTED DEEP LEARNING | CAMMARATA, MICHAEL ROBERT | — |
| 18732214 | ANTI-ROXP ANTIBODIES AND USES THEREOF | MORGAN, BAILEY MICHELLE | — |
| 18666803 | RHODOPSEUDOMONAS PALUSTRIS TIE-1 STRAINS AND METHODS FOR BIOPLASTIC PRODUCTION | MORGAN, BAILEY MICHELLE | — |
| 18286205 | COMPOSITIONS AND METHODS FOR TREATMENT OF CRX-MEDIATED RETINOPATHIES | EBBINGHAUS, BRIANA NOEL | — |
| Art Unit | Apps |
|---|---|
| 3791 | 4 |
| 3798 | 3 |
| 1645 | 3 |
| 1632 | 3 |
| 1678 | 3 |
| 1718 | 2 |
| 3792 | 2 |
| 1614 | 2 |
| 3794 | 2 |
| 1618 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19358923 | ULTRASOUND SENSING AND IMAGING BASED ON WHISPERING-GALLERY-MODE (WGM) MICRORESONATORS | DAVIS, AMELIE R | 3798 | §112Other | Non-Final OA | — | Pending | Oct 15, 2025 |
| 19312085 | RECOMBINANT ADENOVIRUSES AND USE THEREOF | DRISCOLL, LORA E BARNHART | 3991 | §101DP | Non-Final OA | — | Pending | Aug 27, 2025 |
| 19170154 | CATALYST AND METHOD FOR CONVERTING CO2 TO SOLID CARBON, AND COMPOSITES INCLUDING SOLID CARBON | TADAYYON ESLAMI, TABASSOM | 1718 | §102§103§112 | Final Rejection | — | Pending | Apr 04, 2025 |
| 19028550 | BIOMEDICAL PATCHES WITH SPATIALLY ARRANGED FIBERS | SALVATORE, LYNDA | 1789 | DP | Final Rejection | — | Pending | Jan 17, 2025 |
| 18980157 | SYSTEMS AND METHODS FOR AUTOMATED ELECTROCARDIOGRAM (ECG) INTERPRETATION OF WIDE COMPLEX RHYTHMS | ADAMS, WILLIAM PATRICK | 3792 | §101§102§103§112Other | Non-Final OA | — | Pending | Dec 13, 2024 |
| 18970827 | COMPUTATIONAL REFOCUSING-ASSISTED DEEP LEARNING | CAMMARATA, MICHAEL ROBERT | 2667 | §102§103Other | Non-Final OA | — | Pending | Dec 05, 2024 |
| 18855529 | SYSTEMS AND METHODS FOR EXTRACTING CLINICAL PHENOTYPES FOR ALZHEIMER DISEASE DEMENTIA FROM UNSTRUCTURED CLINICAL RECORDS USING NATURAL LANGUAGE PROCESSING | LAGOY, KYRA RAND | 3685 | §101§103§112 | Non-Final OA | 11d overdue | Pending | Oct 09, 2024 |
| 18886294 | Near Infrared Fluorescent Dyes, Formulations and Related Methods | CABRAL, ROBERT S | 1614 | DP | Non-Final OA | — | Pending | Sep 16, 2024 |
| 18830098 | SIGMA-2 RECEPTOR LIGAND DRUG CONJUGATES AS ANTITUMOR COMPOUNDS, METHODS OF SYNTHESIS AND USES THEREOF | PECKHAM, RICHARD GRANT | 1627 | DP | Non-Final OA | — | Pending | Sep 10, 2024 |
| 18844610 | SYSTEMS AND METHODS OF DETERMINING TISSUE PROPERTIES FOR CT-BASED RADIATION THERAPY PLANNING | MALEVIC, DJURA | 2884 | §103 | Final Rejection | — | Pending | Sep 06, 2024 |
| 18818523 | METHODS OF DETECTING ONCOGENIC FUSIONS AND USES THEREOF | LEITH, NANCY J | 1681 | §103§112 | Non-Final OA | 43d overdue | Pending | Aug 28, 2024 |
| 18812459 | Normalization and Calibration for Devices and Systems for Measuring Peripheral Hemodynamics | HENSON, DEVIN B | 3791 | §101§102§103 | Non-Final OA | — | Pending | Aug 22, 2024 |
| 18837721 | SYSTEMS AND METHODS OF CORRECTING MOTION IN IMAGES FOR RADIATION PLANNING | BEKELE, MEKONEN T | 2699 | §103 | Final Rejection | — | Pending | Aug 12, 2024 |
| 18837265 | METHODS OF ASSESSING CANCER | PRAGANI, RAJAN | 1614 | §103§112 | Non-Final OA | — | Pending | Aug 09, 2024 |
| 18780463 | Single Implantable Fiber Device for 2D Dynamic and Reconfigurable Light Emission and Collection | GREEN, TAJANAE NICOLE | 2874 | §102§103 | Non-Final OA | — | Pending | Jul 22, 2024 |
| 18716989 | DEVICE FOR REVERSIBLY BLOCKING ACTIVITIES OF TARGET REGION AND APPLICATIONS OF SAME | CLARK, RYAN T | 3794 | §102§103 | Final Rejection | 5d | Pending | Jun 06, 2024 |
| 18732214 | ANTI-ROXP ANTIBODIES AND USES THEREOF | MORGAN, BAILEY MICHELLE | 1645 | §112 | Non-Final OA | — | Pending | Jun 03, 2024 |
| 18666803 | RHODOPSEUDOMONAS PALUSTRIS TIE-1 STRAINS AND METHODS FOR BIOPLASTIC PRODUCTION | MORGAN, BAILEY MICHELLE | 1645 | §103§112 | Non-Final OA | — | Pending | May 16, 2024 |
| 18646961 | SEPARATORS HAVING OPPOSITELY-CHARGED REGIONS AND SECONDARY BATTERIES INCLUDING THE SAME | MEKHLIN, ELI S | 1759 | §102§103§112 | Non-Final OA | — | Pending | Apr 26, 2024 |
| 18638327 | DEEP NEURAL NETWORKS FOR OUTCOME-ORIENTED PREDICTIONS | PARK, EDWARD | 2675 | §101§103 | Non-Final OA | 62d | Pending | Apr 17, 2024 |
| 18623995 | REGULATOR OF TUMOR CELL FUNCTIONS AND USES THEREOF | CHEONG, CHEOM-GIL | 1645 | §103§112 | Non-Final OA | — | Pending | Apr 01, 2024 |
| 18620007 | ELECTROPORATION AND ELECTROPHORESIS DEVICES, SYSTEMS, AND METHODS RELATED TO ENDOVASCULAR APPLICATIONS | FAIRCHILD, MALLIKA DIPAYAN | 3792 | §103§112 | Final Rejection | 20d | Pending | Mar 28, 2024 |
| 18693320 | SYSTEMS AND METHODS FOR FOCUSED ULTRASOUND-ENABLED LIQUID BIOPSY | HEALY, NOAH MICHAEL | 3791 | §112 | Non-Final OA | — | Pending | Mar 19, 2024 |
| 18600769 | METHODS AND SYSTEMS FOR EXTENDED CULTURE OF HUMAN BLASTOIDS TO POST-IMPLANTATION STAGES ON 3D MATRICES | PRONZATI, GINA | 1633 | §102§103§112 | Non-Final OA | — | Pending | Mar 10, 2024 |
| 18590933 | AEROSOL CONTAINMENT MASK AND METHODS OF USE THEREOF | LEE, MICHELLE J | 3786 | §102§103§112 | Final Rejection | 32d overdue | Pending | Feb 28, 2024 |
| 18586471 | METHODS AND COMPOSITIONS FOR TREATING THROMBOTIC DISEASE | BURKETT, DANIEL JOHN | 1624 | §112 | Final Rejection | — | Pending | Feb 24, 2024 |
| 18682707 | COMPOSITIONS AND METHODS FOR ENHANCING BRAIN PERFUSION | LANDSMAN, ROBERT S | 1647 | §102§103§112 | Non-Final OA | — | Pending | Feb 09, 2024 |
| 18434796 | PRECISION RADIOPHARMACEUTICAL THERAPY OF LYMPHOMA AND OTHER DISEASES | BAEK, JONGHWAN NMN | 1618 | §102§103 | Non-Final OA | — | Pending | Feb 06, 2024 |
| 18400667 | COMPOSITIONS AND METHODS FOR TARGETED CYTOKINE DELIVERY | LI, RUIXIANG | 1674 | §102§112 | Non-Final OA | — | Pending | Dec 29, 2023 |
| 18567428 | SYSTEMS AND METHODS FOR MONITORING PHYSIOLOGICAL STATUS OF LIVING SUBJECT AND ADMINISTERING SUBSTANCES THEREFOR | TURKOWSKI, KAYLA MARIE | 3783 | §103§112 | Non-Final OA | — | Pending | Dec 06, 2023 |
| 18566890 | SYSTEMS AND METHODS FOR TRANSCUTANEOUS AURICULAR VAGAL NERVE STIMULATION TO ENHANCE MOTOR LEARNING, REHABILITATION, AND BCI APPLICATIONS | ANJARIA, SHREYA PARAG | 3796 | §102§103 | Final Rejection | — | Pending | Dec 04, 2023 |
| 18516523 | PLASMA CELL-FREE RNA AND METHODS OF USE THEREOF AS NON-INVASIVE BIOMARKERS FOR ALZHEIMER'S DISEASE | HUDSON, AMY ROSE | 4100 | §101§102§112 | Non-Final OA | — | Pending | Nov 21, 2023 |
| 18503495 | THERAPEUTIC SPLICE-SWITCHING OLIGONUCLEOTIDES FOR CANCER | SHIN, DANA H | 1635 | §102§103§112 | Non-Final OA | — | Pending | Nov 07, 2023 |
| 18286205 | COMPOSITIONS AND METHODS FOR TREATMENT OF CRX-MEDIATED RETINOPATHIES | EBBINGHAUS, BRIANA NOEL | 1632 | §101§103 | Non-Final OA | — | Pending | Oct 09, 2023 |
| 18480409 | CDK4/6 INHIBITORS AS A TREATMENT FOR CLONAL HEMATOPOIESIS | LEE, WILLIAM Y | 1623 | §102§103§112 | Non-Final OA | — | Pending | Oct 03, 2023 |
| 18553411 | COMPOSITIONS FOR BINDING SPHINGOSINE-1-PHOSPHATE RECEPTOR 1 (S1P1), IMAGING OF S1P1, AND PROCESSES FOR PREPARATION THEREOF | JAVANMARD, SAHAR | 1622 | §103Other | Non-Final OA | — | Pending | Sep 29, 2023 |
| 18552936 | RECHARGEABLE ANODE-FREE SODIUM METAL BATTERIES ENABLED BY NON-POROUS SODIUM METAL PLATING AND STRIPPING | SHEIKH, HAROON S | 1751 | §112 | Non-Final OA | — | Pending | Sep 28, 2023 |
| 18472918 | COMPOSITIONS AND METHODS FOR INHIBITION OF ALPHAVIRUS INFECTION | CANELLA, KAREN A | 1643 | §102§112 | Non-Final OA | — | Pending | Sep 22, 2023 |
| 18282933 | SURGICAL DRAIN FOR COLLECTION AND PRESERVATION OF TUMOR-ASSOCIATED BIOMARKERS IN SURGICAL DRAIN FLUID | VU, QUYNH-NHU HOANG | 3783 | §102§103 | Non-Final OA | — | Pending | Sep 19, 2023 |
| 18550797 | SPECTRAL CORRELATION ANALYSIS OF LAYERED EVOLUTIONARY SIGNALS | KALLAL, ROBERT JAMES | 2863 | §101§103§112 | Non-Final OA | — | Pending | Sep 15, 2023 |
| 18466073 | ELECTROLYZER | JACOBSON, SARAH JORDAN | 1785 | §102§103 | Final Rejection | — | Pending | Sep 13, 2023 |
| 18548755 | TRANSCUTANEOUS AURICULAR VAGAL NERVE STIMULATION FOR SUBARACHNOID HEMORRHAGES | STOKLOSA, JOSEPH A | 3794 | §103 | Final Rejection | — | Pending | Sep 01, 2023 |
| 18278707 | MICROBIAL PRODUCTION OF POLYMERIC AMYLOID FIBERS | JOHNSON, TIRONE DEREK | 1675 | §102§103§112 | Non-Final OA | — | Pending | Aug 24, 2023 |
| 18231684 | MUSCLE RETENTION IN AGING AND DUCHENNE MUSCULAR DYSTROPHY (DMD) THROUGH S1P INHIBITION | YU, DAVID TUYANG | 1635 | §103§112DP | Non-Final OA | — | Pending | Aug 08, 2023 |
| 18261874 | METHODS FOR DETECTING utDNA | SALMON, KATHERINE D | 1682 | §112 | Final Rejection | 30d | Pending | Jul 18, 2023 |
| 18260354 | ADJUSTABLE SEAL FOR FLUID MANAGEMENT SYSTEM | STUART, COLIN W | 3791 | §102§103§112 | Non-Final OA | — | Pending | Jul 05, 2023 |
| 18340417 | GENOME-EDITED INVARIANT NATURAL KILLER T (INKT) CELLS FOR THE TREATMENT OF HEMATOLOGIC MALIGNANCIES | VIVLEMORE, TRACY ANN | 1638 | §103 | Non-Final OA | 70d | Pending | Jun 23, 2023 |
| 18317780 | SURFACE-MODIFIED ANASTOMOSIS DEVICE | FUBARA, BLESSING M | 1613 | §102§112 | Non-Final OA | — | Pending | May 15, 2023 |
| 18316294 | METHODS OF DETECTING RESIDUAL DISEASE AND TREATMENT THEREOF | HILL, GRACELYN MARKHAM | 1699 | §101§102§103 | Non-Final OA | — | Pending | May 12, 2023 |
| 18311338 | SYSTEMS AND METHODS FOR EVALUATION AND PREDICTION OF RISK OF MALIGNANT EDEMA AFTER STROKE | BEGEMAN, ANDREW W | 3798 | §112 | Non-Final OA | — | Pending | May 03, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialWashington University has 82 pending office actions as of October 2026, spread across 60 art units and 78 examiners.
Bailey Michelle Morgan has the most, with 2 of Washington University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.